Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FCZG4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 100% obligated
- $2,493.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,493.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra Pen 30 mg/mL. This delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and represents a single delivery under the company's broader pharmaceutical supply agreements.
DMS Pharmaceutical Group Inc. operates as a critical supplier within the Department of Defense's pharmaceutical supply chain, leveraging its established position under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The company holds a single-award Indefinite Delivery Contract designated SPE2DR, valued at $499,999,999 and extending through December 31, 2036, which authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support military healthcare facilities worldwide. This current delivery order exemplifies DMS Pharmaceutical Group's ongoing performance in fulfilling the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCZG4?
SPE2DR26FCZG4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FCZG4 worth?
The government has obligated $2,494 on SPE2DR26FCZG4.
Is contract SPE2DR26FCZG4 an order under another contract?
Yes. SPE2DR26FCZG4 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZG4 competed?
The extent of competition for SPE2DR26FCZG4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award